Clinical Trials
Transcutaneous Electrostimulation
The purpose of this Randomized, double-blinded Controlled Trial is to better understand the causes of scleroderma-associated constipation, see how well Transcutaneous Electrostimulation works for people with different types of scleroderma-associated constipation and develop more effective treatment strategies for patients. The total amount of time you will be in the study is up to 8 weeks.
You will be asked to complete:
- Stool samples
- Blood samples
- Daily surveys about your symptoms
- Abdominal X-rays
- Anorectal Manometry study
Inclusion criteria:
- Be diagnosed with scleroderma
- Be 18 years of age or older
- Be seen by physicians at UTHealth Rheumatology in Houston, Texas
- Be able to give informed consent
- Have symptoms of scleroderma-associated constipation